|
Name |
(2R)-2-[(1R)-4-methylcyclohex-3-en-1-yl]propanoic acid
|
| Molecular Formula | C10H16O2 | |
| IUPAC Name* |
(2R)-2-[(1R)-4-methylcyclohex-3-en-1-yl]propanoic acid
|
|
| SMILES |
CC1=CC[C@@H](CC1)[C@@H](C)C(=O)O
|
|
| InChI |
InChI=1S/C10H16O2/c1-7-3-5-9(6-4-7)8(2)10(11)12/h3,8-9H,4-6H2,1-2H3,(H,11,12)/t8-,9+/m1/s1
|
|
| InChIKey |
QOGOGJNRMJOCKH-BDAKNGLRSA-N
|
|
| Synonyms |
CHEBI:141292; (+)-(4R,8R)-Delta(1)-p-menthen-9-carboxylic acid; (2R)-2-[(1R)-4-methylcyclohex-3-en-1-yl]propanoic acid; (2R)-2-[(1R)-4-methylcyclohex-3-en-1-yl]propionic acid
|
|
| CAS | NA | |
| PubChem CID | 131142768 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 168.23 | ALogp: | 2.2 |
| HBD: | 1 | HBA: | 2 |
| Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 37.3 | Aromatic Rings: | 1 |
| Heavy Atoms: | 12 | QED Weighted: | 0.643 |
| Caco-2 Permeability: | -4.695 | MDCK Permeability: | 0.00002200 |
| Pgp-inhibitor: | 0 | Pgp-substrate: | 0.001 |
| Human Intestinal Absorption (HIA): | 0.016 | 20% Bioavailability (F20%): | 0.011 |
| 30% Bioavailability (F30%): | 0.008 |
| Blood-Brain-Barrier Penetration (BBB): | 0.693 | Plasma Protein Binding (PPB): | 94.33% |
| Volume Distribution (VD): | 0.504 | Fu: | 5.77% |
| CYP1A2-inhibitor: | 0.049 | CYP1A2-substrate: | 0.223 |
| CYP2C19-inhibitor: | 0.025 | CYP2C19-substrate: | 0.517 |
| CYP2C9-inhibitor: | 0.018 | CYP2C9-substrate: | 0.916 |
| CYP2D6-inhibitor: | 0.006 | CYP2D6-substrate: | 0.215 |
| CYP3A4-inhibitor: | 0.013 | CYP3A4-substrate: | 0.077 |
| Clearance (CL): | 6.025 | Half-life (T1/2): | 0.86 |
| hERG Blockers: | 0.005 | Human Hepatotoxicity (H-HT): | 0.546 |
| Drug-inuced Liver Injury (DILI): | 0.191 | AMES Toxicity: | 0.002 |
| Rat Oral Acute Toxicity: | 0.065 | Maximum Recommended Daily Dose: | 0.053 |
| Skin Sensitization: | 0.465 | Carcinogencity: | 0.714 |
| Eye Corrosion: | 0.933 | Eye Irritation: | 0.986 |
| Respiratory Toxicity: | 0.141 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC001066 | ![]() |
0.439 | D03KEK | ![]() |
0.267 | ||
| ENC000555 | ![]() |
0.439 | D09PUL | ![]() |
0.250 | ||
| ENC000511 | ![]() |
0.419 | D08QGD | ![]() |
0.243 | ||
| ENC001296 | ![]() |
0.386 | D0I0EG | ![]() |
0.232 | ||
| ENC001455 | ![]() |
0.339 | D06PSS | ![]() |
0.231 | ||
| ENC002339 | ![]() |
0.333 | D0DZ3X | ![]() |
0.227 | ||
| ENC001981 | ![]() |
0.327 | D08HZC | ![]() |
0.205 | ||
| ENC003255 | ![]() |
0.327 | D06YPU | ![]() |
0.203 | ||
| ENC001641 | ![]() |
0.327 | D0B5LF | ![]() |
0.203 | ||
| ENC001903 | ![]() |
0.327 | D01CKY | ![]() |
0.202 | ||